These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1418026)

  • 1. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome.
    Silver RM; McKinley K; Smith EA; Quearry B; Harati Y; Sternberg EM; Heyes MP
    Arthritis Rheum; 1992 Sep; 35(9):1097-105. PubMed ID: 1418026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
    Silver RM; Sutherland SE; Carreira P; Heyes MP
    J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-tryptophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine.
    Mainetti C; Fathi M; Saurat JH
    Dermatologica; 1991; 183(1):62-5. PubMed ID: 1722762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.
    Silver RM; Heyes MP; Maize JC; Quearry B; Vionnet-Fuasset M; Sternberg EM
    N Engl J Med; 1990 Mar; 322(13):874-81. PubMed ID: 1690352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures.
    Heyes MP; Saito K; Devinsky O; Nadi NS
    Epilepsia; 1994; 35(2):251-7. PubMed ID: 8156942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.
    Saito K; Fujigaki S; Heyes MP; Shibata K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
    Am J Physiol Renal Physiol; 2000 Sep; 279(3):F565-72. PubMed ID: 10966936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
    Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
    Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
    Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
    Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
    Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
    Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
    Sullivan EA; Staehling N; Philen RM
    J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
    Schefold JC; Zeden JP; Pschowski R; Hammoud B; Fotopoulou C; Hasper D; Fusch G; Von Haehling S; Volk HD; Meisel C; Schütt C; Reinke P
    Scand J Infect Dis; 2010 Mar; 42(3):164-71. PubMed ID: 19958238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques.
    Heyes MP; Saito K; Lackner A; Wiley CA; Achim CL; Markey SP
    FASEB J; 1998 Jul; 12(10):881-96. PubMed ID: 9657528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
    Heyes MP; Chen CY; Major EO; Saito K
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.